Phase II study of alternating combination chemotherapy in small cell lung cancer
โ Scribed by Pujol, J.-L.; Demoly, P.; Gautier, V.; Romieu, G.; Dan Aouta, M.; Stenger, R.; Parrat, E.; Tadlaoui, O.; Marcenac, A.M.; Benahmed, S.S.; Michel, F.-B.; Godard, P.
- Book ID
- 123562380
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 749 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background and methods: Fifty-one patients with small cell lung cancer (sclc) were treated with alternating urokinase (uk)-cyclophosphamide-doxorubicin (adriamycin, adria laboratories, columbus, oh)-vincristine and cisplatin-etoposide-vincristine. uk was given as a loading dose of 3000 microgram
Sixty-two patients with small cell carcinoma of lung received cyclic alternating non-cross-resistant combination chemotherapy. Radiation to the chest was given to all the patients. Patients were given a course of VP16, adriamycin and vincristine (VAV) followed by radiation (3,000 rads) to the chest